Emmaus Life Sciences's total assets for Q3 2025 were $20.76M, a decrease of ― from the previous quarter. EMMA total liabilities were $80.24M for the fiscal quarter, a ― a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.